SANJAY DESHPANDE to Antineoplastic Combined Chemotherapy Protocols
This is a "connection" page, showing publications SANJAY DESHPANDE has written about Antineoplastic Combined Chemotherapy Protocols.
Connection Strength
0.253
-
Population Pharmacokinetic and Exposure-Response Analyses of Ibrutinib Combined With Bendamustine and Rituximab in Patients With Mantle Cell Lymphoma. CPT Pharmacometrics Syst Pharmacol. 2025 Oct; 14(10):1562-1574.
Score: 0.140
-
Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma. N Engl J Med. 2022 06 30; 386(26):2482-2494.
Score: 0.113